Stage II/III cancer of the rectosigmoid junction: an independent tumor type?
Mukai M, Kishima K, Yamazaki M, Aoki H, Izumi H, Yamamoto S, Tajima T, Tobita K, Sadahiro S, Yasuda S, Ogoshi K.
Oncol Rep. 2011 Sep;26(3):737-41. doi: 10.3892/or.2011.1343. Epub 2011 Jun 8.
PMID:21667035
Cancer of the Rectum and Rectosigmoid Junction: 20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 266,898 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Adult and Elderly Risk Factors of Mortality in 23,614 Emergently Admitted Patients with Rectal or Rectosigmoid Junction Malignancy.
Levy L, Smiley A, Latifi R.
Int J Environ Res Public Health. 2022 Jul 27;19(15):9203. doi: 10.3390/ijerph19159203.
PMID:35954556
Neoadjuvant chemoradiation versus adjuvant chemotherapy for locally advanced adenocarcinoma of the rectosigmoid junction.
Salami AC, Obaid T, Nweze NJ, Deleon M, Force L, Gorgun E, Wexner S, Joshi ART.
Colorectal Dis. 2020 May;22(5):513-520. doi: 10.1111/codi.14918. Epub 2019 Dec 20.
PMID:31782601
[Cancer of the rectosigmoid junction].
Ionescu A, Sciuca S, Hamburda M, Jutis T, Jakab A, Forai F, Ilea O, Ota A.
Rev Med Chir Soc Med Nat Iasi. 1989 Jan-Mar;93(1):125-7.
PMID:2814017
Adenocarcinomas of the upper third of the rectum and the rectosigmoid junction seem to have similar prognosis as colon cancers even without radiotherapy, SAKK 40/87.
Käser SA, Froelicher J, Li Q, Müller S, Metzger U, Castiglione M, Laffer UT, Maurer CA.